{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:41:29Z","timestamp":1790293289803,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":954,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2013-02355967"],"award-info":[{"award-number":["GR-2013-02355967"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41379-020-0452-0","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T10:18:21Z","timestamp":1578651501000},"page":"1065-1077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-4002","authenticated-orcid":false,"given":"Matteo","family":"Lazzeroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"DeCensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliana","family":"Guerrieri-Gonzaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-394X","authenticated-orcid":false,"given":"Eleonora","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Macis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vingiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Bonizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-4548","authenticated-orcid":false,"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0452-0_bib1","unstructured":"National Comprehensive Cancer Network. Breast cancer version 1.2019. National Comprehensive Cancer Network. 2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_blocks.pdf."},{"issue":"Suppl 5","key":"10.1038\/s41379-020-0452-0_bib2","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0452-0_bib3","unstructured":"National Institute for Health and Care Excellence (NICE). Early and locally advanced breast cancer: diagnosis and management. National Institute for Health and Care Excellence. 2018. https:\/\/www.nice.org.uk\/guidance\/ng101."},{"key":"10.1038\/s41379-020-0452-0_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-020-0452-0_bib5","doi-asserted-by":"crossref","unstructured":"Decensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, et al. Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia. J Clin Oncol. 2019;37:1629\u201337","DOI":"10.1200\/JCO.18.01779"},{"key":"10.1038\/s41379-020-0452-0_bib6","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0452-0_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0452-0_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ajpath.2018.12.003","article-title":"Molecular evaluation of breast ductal carcinoma in situ with oncotype DX DCIS","volume":"189","author":"Nofech-Mozes","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-020-0452-0_bib9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/bjc.2013.147","article-title":"Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype","volume":"108","author":"Lazzeroni","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0452-0_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.01.010","article-title":"Adjuvant therapy in patients with ductal carcinoma in situ of the breast: the Pandora's box","volume":"55","author":"Lazzeroni","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/s41379-020-0452-0_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1755-8794-1-11","article-title":"Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists","volume":"1","author":"Mosley","year":"2008","journal-title":"BMC Med Genom"},{"key":"10.1038\/s41379-020-0452-0_bib12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/sj.bjc.6604746","article-title":"Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types","volume":"99","author":"Starmans","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0452-0_bib13","doi-asserted-by":"crossref","unstructured":"Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008;10:R65.","DOI":"10.1186\/bcr2124"},{"key":"10.1038\/s41379-020-0452-0_bib14","doi-asserted-by":"crossref","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res. Treat. 2006;100:229-235.","DOI":"10.1007\/s10549-006-9242-8"},{"key":"10.1038\/s41379-020-0452-0_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/JTO.0000000000000365","article-title":"Validation of a molecular and pathological model for five-year mortality risk in patients with early stage lung adenocarcinoma","volume":"10","author":"Bueno","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0452-0_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","article-title":"Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-020-0452-0_bib17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol."},{"key":"10.1038\/s41379-020-0452-0_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0452-0_bib19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00345-018-2290-y","article-title":"Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy","volume":"36","author":"Leon","year":"2018","journal-title":"World J Urol"},{"key":"10.1038\/s41379-020-0452-0_bib20","doi-asserted-by":"crossref","first-page":"35241","DOI":"10.18632\/oncotarget.9129","article-title":"Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma","volume":"7","author":"Eguchi","year":"2016","journal-title":"Oncotarget."},{"key":"10.1038\/s41379-020-0452-0_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2018.03.033","article-title":"The cell cycle progression score: unclear role in renal cell carcinoma","volume":"74","author":"Ueno","year":"2018","journal-title":"Eur Urol."},{"key":"10.1038\/s41379-020-0452-0_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jnci\/djj329","article-title":"Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer","volume":"98","author":"Buyse","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0452-0_bib23","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","article-title":"Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series","volume":"13","author":"Desmedt","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0452-0_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-9-394","article-title":"Comparison of prognostic gene expression signatures for breast cancer","volume":"9","author":"Haibe-Kains","year":"2008","journal-title":"BMC Genom"},{"key":"10.1038\/s41379-020-0452-0_bib25","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/bjc.2014.530","article-title":"Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer","volume":"111","author":"Stephen","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0452-0_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S1470-2045(13)70387-5","article-title":"Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population","volume":"14","author":"Sgroi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1038\/s41379-020-0452-0_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(02)09838-0","article-title":"Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer","volume":"360","author":"Klein","year":"2002","journal-title":"Lancet."},{"key":"10.1038\/s41379-020-0452-0_bib28","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1038\/s41379-020-0452-0_bib29","first-page":"P1","article-title":"Prognostic and predictive relevance of cell cycle progression (CCP) score in ductal carcinoma in situ: Results from the UK\/ANZ DCIS trial","volume":"77","author":"Thorat","year":"2017","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0452-0_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00348201","article-title":"Role of radiotherapy following total mastectomy in patients with early breast cancer. The Closed Trials Working Party of the CRC Breast Cancer Trials Group","volume":"18","author":"Houghton","year":"1994","journal-title":"World J Surg"},{"key":"10.1038\/s41379-020-0452-0_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/bjs.1800810321","article-title":"Local recurrence after simple mastectomy","volume":"8","author":"O'Rourke","year":"1994","journal-title":"Br J Surg"},{"key":"10.1038\/s41379-020-0452-0_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.critrevonc.2019.04.016","article-title":"The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: suggestions for routine practice","volume":"138","author":"Montero-Luis","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/s41379-020-0452-0_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/ijc.30254","article-title":"Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS","volume":"139","author":"Guerrieri-Gonzaga","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-020-0452-0_bib34","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","article-title":"Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent","volume":"83","author":"Jordan","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-0452-0_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-011-1387-4","article-title":"Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis","volume":"127","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/s41379-020-0452-0_bib36","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1097-0142(19930415)71:8<2532::AID-CNCR2820710817>3.0.CO;2-0","article-title":"Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast\u2013conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment","volume":"71","author":"Solin","year":"1993","journal-title":"Cancer."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0452-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222008365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0452-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:40:27Z","timestamp":1760229627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222008365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0893395222008365"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0452-0","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0452-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}